EDTUTC-4 New YorkLog in Sign up

LSTA
Lisata Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseOct 27, 2026 3:44:31 PM EDT

1.03USD-2.830%(-0.03)40,773

0.8900Bid1.1900Ask0.3000Spread

LSTA News

Day breaks

04:05 PM EDTLisata Therapeutics Appoints Jeff Farrow to Board of Directors ·

GlobeNewswire Inc.

08:00 AM EDTMarea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly ·

GlobeNewswire Inc.

06:38 PM EDTEQUITY ALERT - The M&A Class Action Firm Launches Inquiry -- LSTA, FSHP, BWIN, and ACVA ·

PR Newswire

02:04 PM EDTLSTA, Inc. Welcomes SEC Proposal Clarifying Treatment of Discretionary Trading Authority Under Custody Rule ·

Business Wire

08:08 PM EDTLisata Therapeutics (LSTA) Buys Marea and Signs $225M Financing. Is the Dilution Worth it? ·

Insider Monkey

10:15 AM EDTLisata Therapeutics acquires Marea Therapeutics, secures $225 million private placement ·

Proactive

09:50 AM EDTLisata Therapeutics Acquires Marea Therapeutics; Announces Concurrent Private Placement ·

RTTNews

09:26 AM EDTLisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement ·

GlobeNewswire Inc.